ONCOTELIC THERAPEUTCS INC (OTLC) SEC filings
OTLC SEC filings moved a median of -0.31% by the close. OTLC SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the OTLC overview →
52 measured OTLC SEC filing events.
Where these OTLC SEC filings landedvs 52 measured OTLC SEC filing reactions
| Middle 50% of OTLC SEC filing reactions | -4.42% to +4.28% |
|---|---|
| Median reaction (to close) | -0.31% |
| Measured reactions | 52 |
Point-in-time · zero look-ahead
Half of the 52 OTLC SEC filing events with a measured close landed between -4.42% and +4.28%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Oncotelic Therapeutics, For: Oct 07 | SEC filing · Form 8-K | +0.00% | -1.00% | |
| Form 10-Q Oncotelic Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.25% | |
| Form 8-K Oncotelic Therapeutics, For: Aug 03 | SEC filing · Form 8-K | +0.00% | -0.70% | |
| Form D Oncotelic Therapeutics, | SEC filing · Form D | +0.00% | -10.51% | |
| Form 8-K Oncotelic Therapeutics, For: Jul 10 | SEC filing · Form 8-K | +0.00% | +6.36% | |
| Form 8-K Oncotelic Therapeutics, For: Jul 13 | SEC filing · Form 8-K | +0.00% | +6.36% | |
| Form 8-K Oncotelic Therapeutics, For: Jun 23 | SEC filing · Form 8-K | +0.00% | +2.81% | |
| Form 10-Q Oncotelic Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -14.65% | -6.67% | |
| Form 8-K Oncotelic Therapeutics, For: May 01 | SEC filing · Form 8-K | +0.00% | -6.95% | |
| Form 8-K Oncotelic Therapeutics, For: Apr 16 | SEC filing · Form 8-K | +0.12% | +5.49% | |
| Form 10-K Oncotelic Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.12% | +5.49% | |
| Form 8-K Oncotelic Therapeutics, For: Mar 31 | SEC filing · Form 8-K | +12.50% | -2.85% | |
| Form NT 10-K Oncotelic Therapeutics, For: Dec 31 | SEC filing · Form NT | +0.00% | +0.32% | |
| Form 8-K Oncotelic Therapeutics, For: Mar 23 | SEC filing · Form 8-K | +0.00% | -6.56% | |
| Form 8-K Oncotelic Therapeutics, For: Mar 24 | SEC filing · Form 8-K | +0.00% | -6.56% | |
| Form 8-K Oncotelic Therapeutics, For: Jan 23 | SEC filing · Form 8-K | +0.00% | -2.52% | |
| Form 8-K Oncotelic Therapeutics, For: Jan 22 | SEC filing · Form 8-K | +0.00% | +9.56% | |
| Form 8-K Oncotelic Therapeutics, For: Jan 02 | SEC filing · Form 8-K | -10.56% | -5.33% | |
| Form 8-K Oncotelic Therapeutics, For: Dec 31 | SEC filing · Form 8-K | +0.00% | +6.31% | |
| Form 8-K Oncotelic Therapeutics, For: Dec 23 | SEC filing · Form 8-K | +0.00% | -0.76% | |
| Form EFFECT Oncotelic Therapeutics, | SEC filing · Form EFFECT | +0.00% | -0.63% | |
| Form 8-K Oncotelic Therapeutics, For: Dec 22 | SEC filing · Form 8-K | +0.00% | -1.15% | |
| Form S-1/A Oncotelic Therapeutics, | SEC filing · Form S-1 | +0.00% | -1.15% | |
| Form D Oncotelic Therapeutics, | SEC filing · Form D | +0.00% | +4.36% | |
| Form 8-K Oncotelic Therapeutics, For: Dec 04 | SEC filing · Form 8-K | +0.00% | -2.99% | |
| Form S-1 Oncotelic Therapeutics, | SEC filing · Form S-1 | +3.33% | -1.11% | |
| Form 10-Q Oncotelic Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form NT 10-Q Oncotelic Therapeutics, For: Sep 30 | SEC filing · Form NT | +0.00% | +11.12% | |
| Form 8-K Oncotelic Therapeutics, For: Oct 21 | SEC filing · Form 8-K | +1.30% | +4.25% | |
| Form 10-Q Oncotelic Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K Oncotelic Therapeutics, For: Aug 06 | SEC filing · Form 8-K | -0.23% | +16.28% | |
| Form 8-K Oncotelic Therapeutics, For: Jul 31 | SEC filing · Form 8-K | +11.44% | +12.16% | |
| Form 10-Q Oncotelic Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +15.04% | +1.76% | |
| Form EFFECT Oncotelic Therapeutics, | SEC filing · Form EFFECT | +2.00% | +7.47% | |
| Form 10-K Oncotelic Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.60% | |
| Form POS AM Oncotelic Therapeutics, | SEC filing · Form POS | +0.00% | +3.60% | |
| Form NT 10-K Oncotelic Therapeutics, For: Dec 31 | SEC filing · Form NT | — | +6.92% | |
| Form 8-K Oncotelic Therapeutics, For: Mar 23 | SEC filing · Form 8-K | — | -1.82% | |
| Form 8-K Oncotelic Therapeutics, For: Dec 31 | SEC filing · Form 8-K | +0.00% | -5.56% | |
| Form 10-Q Oncotelic Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -27.59% | |
| Form NT 10-Q Oncotelic Therapeutics, For: Sep 30 | SEC filing · Form NT | +0.00% | +4.01% | |
| Form 10-Q Oncotelic Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | -6.00% | |
| Form 10-Q Oncotelic Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +11.11% | +0.00% | |
| Form 8-K Oncotelic Therapeutics, For: Apr 26 | SEC filing · Form 8-K | +0.00% | -4.54% | |
| Form EFFECT Oncotelic Therapeutics, | SEC filing · Form EFFECT | +0.00% | -10.00% | |
| Form POS AM Oncotelic Therapeutics, | SEC filing · Form POS | +0.00% | -1.50% | |
| Form 10-K Oncotelic Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.24% | |
| Form POS AM Oncotelic Therapeutics, | SEC filing · Form POS | +0.00% | +0.24% | |
| Form NT 10-K Oncotelic Therapeutics, For: Dec 31 | SEC filing · Form NT | +0.00% | +4.72% | |
| Form 8-K Oncotelic Therapeutics, For: Jan 29 | SEC filing · Form 8-K | +0.00% | -4.38% | |
| Form 10-Q Oncotelic Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -23.26% | |
| Form 8-K Oncotelic Therapeutics, For: Oct 24 | SEC filing · Form 8-K | +0.00% | -12.57% |
Keep exploring
More OTLC: earnings → · analyst actions → · OTLC overview →